Chronic Anal Fissure Clinical Trial
Official title:
Percutaneous Tibial Nerve Stimulation - PTNS: an Alternative Treatment Option for Chronic Therapy Resistant Anal Fissure
At a tertiary referral centre, 10 patients (4 male and 6 female; mean age 49.8 years) were given neuromodulation via the posterior tibial nerve to the sacral nerve for 30 min on 10 consecutive days. All patients had failed conventional medical treatment. The visual analogue scale (VAS), St. Marks score, Wexner`s constipation score, Brief Pain Inventory (BPI - SF), bleeding and mucosal healing were evaluated before treatment, at termination, after 3 months and then yearly during three years.
Between October 2013 and January 2014, 10 patients diagnosed with chronic anal fissure at the
Pelvic Floor Centre - University Hospital of Malmo, Sweden were treated with percutaneous
tibial nerve stimulation. Ethical clearance to use the results in a scientific setting was
obtained from the ethics committee of the University of Lund, Sweden (Dnr 2016/998).
Pre-treatment evaluation included detailed medical history and anorectal examination. All
patients presented with pain and/or bleeding and the presence of a chronic anal fissure was
confirmed by clinical examination.
Patients were included in the study if they were older than 18 years and had symptoms of
chronic anal fissure for at least 6 months. All patients must have been on high fiber diet
and stool softeners and in addition failed all conservative pharmacological treatment with
topical application of anaesthetic creams, muscle relaxants (nitroglycerin or diltiazem)
and/or botulinum toxin injection. We excluded patients with pregnancy, pacemaker device, low
molecular heparin or warfarin treatment, neurological disease, inflammatory bowel disease and
radiation proctitis. The Visual Analog Scale (VAS), St. Marks Incontinence Score, Wexner´s
Constipation Score, Brief Pain Inventory - Short form (BPI-SF), symptom relief, bleeding and
mucosal fissure healing were evaluated before and after treatment. VAS and BPI-SF were used
to measure subjective pain characteristics and symptoms of patients at baseline, after two
weeks (end of treatment), three months and then after one, two and three years. St. Marks
Score and Wexner´s Constipation Score were evaluated in the same way though only up to one
year after completion of treatment. The patients were given percutaneous tibial nerve
stimulation after obtaining informed consent. The procedure was performed by two experienced
pelvic floor therapists. Patients retained their high fiber diet and stool softeners during
the procedure. Percutaneous tibial nerve stimulation was performed by using the Urgent PC
Neuromodulation System ® (Uroplasty, Holland) on an outpatient basis. A stimulator provides
electrical current with a fixed pulse frequency of 20Hz, pulse width 200 µ seconds and
current setting between 0.5 and 9 mA (amplitude). A surface electrode was placed at the
medial arch of the midfoot and a needle electrode was inserted through the skin posterior to
the medial malleolus and advanced towards the posterior tibial nerve. Stimulation was
gradually increased until a tingling sensation was perceived in the foot, or a motor flexor
response was observed at the big toe. All patients received the treatment for 30 minutes 5
days a week, during 2 consecutive weeks. The clinical state of the fissure was evaluated
before and after the last treatment session as well at three months and one year (though at
the 3 month follow up one patient declined clinical examination since he felt completely
symptom free). The fissure wound was characterized as not healed, partially healed when the
healing process was visible but not totally complete and healed when no sign of the fissure
was visible. At two and three years all patients were contacted by phone, and those who had
symptoms where chronic anal fissure could not be ruled out underwent a clinical examination.
Statistical analyses:
The clinical outcome i.e. none healed, partially or totally healed fissure was analysed in
relation to VAS, mean of St. Marks Incontinence Score and sum of Wexners's Constipation
Score. These questions were chosen due to their clinical importance and high response rate.
All analyses were calculated with descriptive statistics due to the few amount of patients.
All analyses were performed with SPSS 22.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05598164 -
Botulinum Toxin Type A in the Treatment of Chronic Anal Fissure
|
N/A | |
Terminated |
NCT02158013 -
Treatment Of Chronic Anal Fissure
|
N/A | |
Completed |
NCT01217515 -
Diltiazem Hydrochloride Cream for Anal Fissure
|
Phase 3 | |
Recruiting |
NCT05117697 -
Surgical Treatment of a Chronic Anal Fissure
|
N/A | |
Completed |
NCT02527109 -
The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients With Anal Fissure
|
Phase 2/Phase 3 | |
Recruiting |
NCT03920449 -
Postero-lateral Internal Sphincterotomy vs Botulinum Toxin Injection in the Treatment of Chronic Anal Fissure
|
N/A | |
Enrolling by invitation |
NCT04793347 -
Effect of Shock Waves Therapy on Chronic Anal Fissure
|
N/A | |
Completed |
NCT04166175 -
High Dose Multiple Site Injection of Botox Versus Lateral Sphincterotomy in Chronic Analfissure
|
N/A | |
Completed |
NCT02395809 -
Transcutaneous Posterior Tibial Nerve Stimulation for Treatment of Chronic Anal Fissure
|
N/A | |
Completed |
NCT01500889 -
Conventional Lateral Internal Sphincterotomy, V-Y Anoplasty and Tailored Lateral Internal Sphincterotomy With V-YF in Treatment of Chronic Anal Fissure(CAF)
|
N/A | |
Completed |
NCT01132391 -
Perianal Versus Endoanal Application of Glyceryl Trinitrate 0.4% Ointment for Chronic Anal Fissure
|
Phase 3 | |
Completed |
NCT03872765 -
Outcomes of the Use of CO2 (Carbon Dioxide) Laser in the Treatment of Chronic Anal Fissure
|
N/A | |
Completed |
NCT00972907 -
An Open Label Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing in Human Subjects
|
Phase 1/Phase 2 |